Manufacturer of Controlled Substances; Notice of Registration, 45788-45789 [E8-18042]
Download as PDF
<![CDATA[
45788
Federal Register / Vol. 73, No. 152 / Wednesday, August 6, 2008 / Notices
Dated: July 28, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–17973 Filed 8–4–08; 8:45 am]
the basic classes of controlled
substances listed.
Dated: July 28, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–17974 Filed 8–4–08; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
Manufacturer of Controlled
Substances; Notice of Registration
Drug Enforcement Administration
By Notice dated March 28, 2008, and
published in the Federal Register on
April 4, 2008 (73 FR 18570), Siegfried
(USA), Inc., Industrial Park Road,
Pennsville, New Jersey 08070, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedules I and II:
Drug
Schedule
mstockstill on PROD1PC66 with NOTICES
Dihydromorphine (9145) ...............
Amphetamine (1100) ....................
Methamphetamine (1105) .............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) .................
Hydrocodone (9193) .....................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Oxymorphone (9652) ....................
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
16:46 Aug 05, 2008
II
II
Jkt 214001
By Notice dated March 10, 2008 and
published in the Federal Register on
March 19, 2008 (73 FR 14840),
Mallinckrodt, Inc., 3600 North Second
Street, St. Louis, Missouri 63147, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedules I and II:
Drug
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Siegfried (USA), Inc., to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Siegfried (USA), Inc., to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
VerDate Aug<31>2005
Manufacturer of Controlled
Substances; Notice of Registration
Schedule
Tetrahydrocannabinols (7370) .....
Codeine-N-oxide (9053) ...............
Dihydromorphine (9145) ...............
Difenoxin (9168) ...........................
Morphine-N-oxide (9307) .............
Normorphine (9313) .....................
Norlevorphanol (9634) ..................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Nabilone (7379) ............................
Codeine (9050) .............................
Diprenorphine (9058) ...................
Etorphine HCL (9059) ..................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Levorphanol (9220) ......................
Meperidine (9230) ........................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Metopon (9260) ............................
Dextropropoxyphene, bulk (9273)
Morphine (9300) ...........................
Thebaine (9333) ...........................
Opium extracts (9610) ..................
Opium fluid extract (9620) ............
Opium tincture (9630) ..................
Opium, powdered (9639) .............
Opium, granulated (9640) ............
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Phenazocine (9715) .....................
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
PO 00000
Frm 00096
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The firm plans to manufacture the
listed controlled substances for internal
use and for sale to other companies.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Mallinckrodt, Inc. to manufacture the
listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Mallinckrodt, Inc. to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: July 30, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–18039 Filed 8–5–08; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated March 11, 2008 and
published in the Federal Register on
March 19, 2008 (73 FR 14841), Varian,
Inc., Lake Forest, 25200 Commercentre
Drive, Lake Forest, California 92630–
8810, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in schedule
II:
Drug
Phencyclidine (7471) ....................
1-Piperidinocyclohexanecarbonitrile (8603).
Benzoylecgonine (9180) ...............
Schedule
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances for use in diagnostic
products.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Varian, Inc. to manufacture the listed
E:\FR\FM\06AUN1.SGM
06AUN1
Federal Register / Vol. 73, No. 152 / Wednesday, August 6, 2008 / Notices
basic classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Varian,
Inc. to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: July 30, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–18042 Filed 8–5–08; 8:45 am]
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with State
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: July 30, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–18067 Filed 8–5–08; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Employment Standards Administration
BILLING CODE 4410–09–P
Proposed Extension of the Approval of
Information Collection Requirements
DEPARTMENT OF JUSTICE
ACTION:
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated April 9, 2008, and
published in the Federal Register on
April 16, 2008, (73 FR 20718), Research
Triangle Institute, Kenneth H. Davis Jr.,
Hermann Building, East Institute Drive,
P.O. Box 12194, Research Triangle,
North Carolina 27709, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
schedules I and II:
Drug
Schedule
mstockstill on PROD1PC66 with NOTICES
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Cocaine (9041) .............................
I
I
II
The Institute will manufacture small
quantities of cocaine and marihuana
derivatives for use by their customers in
analytical kits, reagents, and reference
standards as directed by the National
Institute on Drug Abuse.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Research Triangle Institute to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Research Triangle Institute
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
VerDate Aug<31>2005
16:46 Aug 05, 2008
Jkt 214001
Notice.
SUMMARY: The Department of Labor, as
part of its continuing effort to reduce
paperwork and respondent burden,
conducts a preclearance consultation
program to provide the general public
and Federal agencies with an
opportunity to comment on proposed
and/or continuing collections of
information in accordance with the
Paperwork Reduction Act of 1995
(PRA95) [44 U.S.C. 3506(c)(2)(A)]. This
program helps to ensure that requested
data can be provided in the desired
format, reporting burden (time and
financial resources) is minimized,
collection instruments are clearly
understood, and the impact of collection
requirements on respondents can be
properly assessed. Currently, the
Employment Standards Administration
is soliciting comments concerning the
proposal to extend OMB approval of the
information collection: Work
Experience and Career Exploration
(WECEP) Regulations, 29 CFR 570.35a.
A copy of the proposed information
collection request can be obtained by
contacting the office listed below in the
addresses section of this Notice.
DATES: Written comments must be
submitted to the office listed in the
addresses section below on or before
October 6, 2008.
ADDRESSES: Ms. Hazel M. Bell, U.S.
Department of Labor, 200 Constitution
Ave., NW., Room S–3201, Washington,
DC 20210, telephone (202) 693–0418,
fax (202) 693–1451, E-mail
bell.hazel@dol.gov. Please use only one
PO 00000
Frm 00097
Fmt 4703
Sfmt 4703
45789
method of transmission for comments
(mail, fax, or E-mail).
SUPPLEMENTARY INFORMATION
I. Background: The Fair Labor
Standards Act (FLSA) section 3(l), 29
U.S.C. 203(l), establishes a minimum
age of 16 years for most nonagricultural
employment but allows the employment
of 14- and 15-year olds in occupations
other than manufacturing and mining or
deemed hazardous, if the Secretary of
Labor determines such employment is
confined to (1) periods that will not
interfere with the minor’s schooling and
(2) conditions that will not interfere
with the minor’s health and well-being.
FLSA section 11(c), 29 U.S.C. 211(c),
requires all employers covered by the
FLSA to make, keep and preserve
records of their employees’ wages, hours
and other conditions and practices of
employment. Regulations issued by the
Secretary of Labor prescribe the
recordkeeping and reporting
requirements for these records. Subpart
C of Regulations, 29 CFR Part 570, Child
Labor Regulations, Orders, and
Statements of Interpretation, sets forth
the employment standards for 14- and
15-year olds (CL Reg. 3). Regulations 29
CFR 570.35a contains the requirements
and criteria for the use of 14- and 15year olds and the occupations permitted
for them, and the conditions of
employment that allow for the
employment of 14- and 15-year olds,
pursuant to a school-supervised and
school-administered WECEP—under the
conditions CL Reg. 3 otherwise
prohibits. In order to utilize the CL Reg.
3 WECEP provisions, Regulations 29
CFR 570.35a(b)(2) requires a state
educational agency to file an application
for approval of a state WECEP program
as one not interfering with schooling or
with the health and well-being of the
minors involved. Regulations 29 CFR
570.35a(b)(3)(vi) requires the
preparation of a written training
agreement for each student participating
in a WECEP and that such agreement be
signed by the teacher-coordinator,
employer, and student. The regulation
also requires the student’s parent or
guardian to sign or otherwise consent to
the agreement in order for it to be valid.
Regulations 29 CFR 570.35a(b)(4)(ii)
requires state education agencies to
keep a record of the names and
addresses of each school enrolling
WECEP students and the number of
enrollees in each unit. The state or local
educational agency office must keep a
copy of the written training agreement
for each student participating in the
WECEP. The records and copies must be
maintained for three (3) years from the
date of each student’s enrollment in the
E:\FR\FM\06AUN1.SGM
06AUN1
]]>Agencies
[Federal Register Volume 73, Number 152 (Wednesday, August 6, 2008)]
[Notices]
[Pages 45788-45789]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-18042]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated March 11, 2008 and published in the Federal
Register on March 19, 2008 (73 FR 14841), Varian, Inc., Lake Forest,
25200 Commercentre Drive, Lake Forest, California 92630-8810, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled
substances listed in schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Phencyclidine (7471)....................... II
1-Piperidinocyclohexane-carbonitrile (8603) II
Benzoylecgonine (9180)..................... II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances for use in diagnostic products.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Varian, Inc. to manufacture the listed
[[Page 45789]]
basic classes of controlled substances is consistent with the public
interest at this time. DEA has investigated Varian, Inc. to ensure that
the company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: July 30, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-18042 Filed 8-5-08; 8:45 am]
BILLING CODE 4410-09-P
